SEC Form 4 · accession 0001567619-19-005600
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory David Kitchener
Officer — Chief Financial Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.78 | Feb 26, 2019 | A | 25,000 | A | — | Feb 26, 2029 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F125% of the shares underlying the stock option will vest on February 26, 2020, and the remaining shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary thereafter, so that all shares shall have vested on February 26, 2023.